Stem-cell stocks regain ground

Posted on August 26, 2010 at 15:27 PM EDT

Shares of stem-cell researchers regain ground, after being pushed down earlier in the week on investor concerns that a court ruling against the federal funding of embryonic stem-cell research would negatively impact the fledgling sector.

Related Stocks:

AASTROM BIOSCIENCES Athersys, Inc. Cytori Therapeutics, Inc. Geron Corp Osiris Therapeutics, Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates